Cargando…

A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India

Although current programmes to eliminate lymphatic filariasis have made significant progress it may be necessary to use different approaches to achieve the global goal, especially where compliance has been poor and ‘hot spots’ of continued infection exist. In the absence of alternative drugs, the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Kar, Shantanu Kumar, Dwibedi, Bhagirathi, Kerketa, Anna Salomi, Maharana, Antaryami, Panda, Sudanshu S, Mohanty, Prafulla Chandra, Horton, John, Ramachandran, Cherubala P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363665/
https://www.ncbi.nlm.nih.gov/pubmed/25781977
http://dx.doi.org/10.1371/journal.pntd.0003583
_version_ 1782361952878592000
author Kar, Shantanu Kumar
Dwibedi, Bhagirathi
Kerketa, Anna Salomi
Maharana, Antaryami
Panda, Sudanshu S
Mohanty, Prafulla Chandra
Horton, John
Ramachandran, Cherubala P
author_facet Kar, Shantanu Kumar
Dwibedi, Bhagirathi
Kerketa, Anna Salomi
Maharana, Antaryami
Panda, Sudanshu S
Mohanty, Prafulla Chandra
Horton, John
Ramachandran, Cherubala P
author_sort Kar, Shantanu Kumar
collection PubMed
description Although current programmes to eliminate lymphatic filariasis have made significant progress it may be necessary to use different approaches to achieve the global goal, especially where compliance has been poor and ‘hot spots’ of continued infection exist. In the absence of alternative drugs, the use of higher or more frequent dosing with the existing drugs needs to be explored. We examined the effect of higher and/or more frequent dosing with albendazole with a fixed 300mg dose of diethylcarbamazine in a Wuchereria bancrofti endemic area in Odisha, India. Following screening, 104 consenting adults were randomly assigned to treatment with the standard regimen annually for 24 months (S1), or annually with increased dose (800mg albendazole)(H1) or with increased frequency (6 monthly) with either standard (S2) or increased (H2) dose. Pre-treatment microfilaria counts (GM) ranged from 348 to 459 mf/ml. Subjects were followed using microfilaria counts, OG4C3 antigen levels and ultrasound scanning for adult worm nests. Microfilarial counts tended to decrease more rapidly with higher or more frequent dosing at all time points. At 12 months, Mf clearance was marginally greater with the high dose regimens, while by 24 months, there was a trend to higher Mf clearance in the arm with increased frequency and 800mg of albendazole (76.9%) compared to other arms, (S1:64%, S2:69.2% & H1:73.1%). Although higher and/or more frequent dosing showed a trend towards a greater decline in antigenemia and clearance of “nests”, all regimens demonstrated the potential macrofilaricidal effect of the combination. The higher doses of albendazole did not result in a greater number or more severe side effects. The alternative regimens could be useful in the later stages of existing elimination programmes or achieving elimination more rapidly in areas where programmes have yet to start.
format Online
Article
Text
id pubmed-4363665
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43636652015-03-23 A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India Kar, Shantanu Kumar Dwibedi, Bhagirathi Kerketa, Anna Salomi Maharana, Antaryami Panda, Sudanshu S Mohanty, Prafulla Chandra Horton, John Ramachandran, Cherubala P PLoS Negl Trop Dis Research Article Although current programmes to eliminate lymphatic filariasis have made significant progress it may be necessary to use different approaches to achieve the global goal, especially where compliance has been poor and ‘hot spots’ of continued infection exist. In the absence of alternative drugs, the use of higher or more frequent dosing with the existing drugs needs to be explored. We examined the effect of higher and/or more frequent dosing with albendazole with a fixed 300mg dose of diethylcarbamazine in a Wuchereria bancrofti endemic area in Odisha, India. Following screening, 104 consenting adults were randomly assigned to treatment with the standard regimen annually for 24 months (S1), or annually with increased dose (800mg albendazole)(H1) or with increased frequency (6 monthly) with either standard (S2) or increased (H2) dose. Pre-treatment microfilaria counts (GM) ranged from 348 to 459 mf/ml. Subjects were followed using microfilaria counts, OG4C3 antigen levels and ultrasound scanning for adult worm nests. Microfilarial counts tended to decrease more rapidly with higher or more frequent dosing at all time points. At 12 months, Mf clearance was marginally greater with the high dose regimens, while by 24 months, there was a trend to higher Mf clearance in the arm with increased frequency and 800mg of albendazole (76.9%) compared to other arms, (S1:64%, S2:69.2% & H1:73.1%). Although higher and/or more frequent dosing showed a trend towards a greater decline in antigenemia and clearance of “nests”, all regimens demonstrated the potential macrofilaricidal effect of the combination. The higher doses of albendazole did not result in a greater number or more severe side effects. The alternative regimens could be useful in the later stages of existing elimination programmes or achieving elimination more rapidly in areas where programmes have yet to start. Public Library of Science 2015-03-17 /pmc/articles/PMC4363665/ /pubmed/25781977 http://dx.doi.org/10.1371/journal.pntd.0003583 Text en © 2015 Kar et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kar, Shantanu Kumar
Dwibedi, Bhagirathi
Kerketa, Anna Salomi
Maharana, Antaryami
Panda, Sudanshu S
Mohanty, Prafulla Chandra
Horton, John
Ramachandran, Cherubala P
A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
title A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
title_full A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
title_fullStr A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
title_full_unstemmed A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
title_short A Randomized Controlled Trial of Increased Dose and Frequency of Albendazole with Standard Dose DEC for Treatment of Wuchereria bancrofti Microfilaremics in Odisha, India
title_sort randomized controlled trial of increased dose and frequency of albendazole with standard dose dec for treatment of wuchereria bancrofti microfilaremics in odisha, india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363665/
https://www.ncbi.nlm.nih.gov/pubmed/25781977
http://dx.doi.org/10.1371/journal.pntd.0003583
work_keys_str_mv AT karshantanukumar arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT dwibedibhagirathi arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT kerketaannasalomi arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT maharanaantaryami arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT pandasudanshus arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT mohantyprafullachandra arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT hortonjohn arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT ramachandrancherubalap arandomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT karshantanukumar randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT dwibedibhagirathi randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT kerketaannasalomi randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT maharanaantaryami randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT pandasudanshus randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT mohantyprafullachandra randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT hortonjohn randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia
AT ramachandrancherubalap randomizedcontrolledtrialofincreaseddoseandfrequencyofalbendazolewithstandarddosedecfortreatmentofwuchereriabancroftimicrofilaremicsinodishaindia